Page
%P
-
Article
Open AccessStop** targeted therapy for complete responders in advanced BRAF mutant melanoma
BRAF inhibitors revolutionised the management of melanoma patients and although resistance occurs, there is a subgroup of patients who maintain durable disease control. For those cases with durable complete re...